Quantbot Technologies LP Purchases 137,541 Shares of Doximity, Inc. $DOCS

Key Points

• Quantbot Technologies LP increased its stake in Doximity, Inc. by 182.6% during the 1st quarter, owning 212,868 shares valued at approximately $12.35 million.
• Doximity reported an earnings per share (EPS) of $0.36 for the last quarter, exceeding analysts' expectations of $0.31 and marking a 15.2% increase in quarterly revenue compared to the same period last year.
• Insider activity showed that directors sold a total of 36,000 shares valued at over $2.14 million in the past three months, indicating potential shifts in confidence among company leadership.

Quantbot Technologies LP increased its holdings in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) by 182.6% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 212,868 shares of the company's stock after buying an additional 137,541 shares during the quarter. Quantbot Technologies LP owned 0.11% of Doximity worth $12,353,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also modified their holdings of DOCS. VSM Wealth Advisory LLC purchased a new position in Doximity in the first quarter valued at about $29,000. Allworth Financial LP grew its stake in Doximity by 104.0% in the first quarter. Allworth Financial LP now owns 563 shares of the company's stock valued at $32,000 after purchasing an additional 287 shares in the last quarter. National Bank of Canada FI purchased a new position in Doximity in the first quarter valued at about $33,000. Spire Wealth Management grew its stake in Doximity by 73.2% in the first quarter. Spire Wealth Management now owns 615 shares of the company's stock valued at $36,000 after purchasing an additional 260 shares in the last quarter. Finally, Brooklyn Investment Group grew its stake in Doximity by 70.7% in the first quarter. Brooklyn Investment Group now owns 746 shares of the company's stock valued at $43,000 after purchasing an additional 309 shares in the last quarter. Hedge funds and other institutional investors own 87.19% of the company's stock.

Insider Buying and Selling

In related news, Director Timothy S. Cabral sold 10,000 shares of the business's stock in a transaction dated Wednesday, June 25th. The stock was sold at an average price of $60.00, for a total transaction of $600,000.00. Following the completion of the transaction, the director owned 6,360 shares of the company's stock, valued at approximately $381,600. The trade was a 61.12% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Regina M. Benjamin sold 10,000 shares of the business's stock in a transaction dated Wednesday, June 25th. The stock was sold at an average price of $60.00, for a total value of $600,000.00. Following the transaction, the director directly owned 16,618 shares of the company's stock, valued at $997,080. This represents a 37.57% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 36,000 shares of company stock valued at $2,140,940. Insiders own 31.30% of the company's stock.

Doximity Price Performance

Shares of NASDAQ DOCS traded up $0.7980 during trading hours on Wednesday, hitting $64.4080. 1,931,944 shares of the company's stock were exchanged, compared to its average volume of 2,336,196. Doximity, Inc. has a 1-year low of $35.32 and a 1-year high of $85.21. The stock has a market capitalization of $12.06 billion, a price-to-earnings ratio of 64.41, a PEG ratio of 4.10 and a beta of 1.36. The company's 50-day moving average price is $60.42 and its 200-day moving average price is $60.37.

Doximity (NASDAQ:DOCS - Get Free Report) last posted its quarterly earnings data on Thursday, August 7th. The company reported $0.36 earnings per share for the quarter, topping the consensus estimate of $0.31 by $0.05. Doximity had a return on equity of 21.75% and a net margin of 36.60%.During the same quarter in the previous year, the firm posted $0.28 earnings per share. The firm's revenue was up 15.2% compared to the same quarter last year. Doximity has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. On average, research analysts expect that Doximity, Inc. will post 0.99 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of research analysts have commented on DOCS shares. Truist Financial boosted their target price on Doximity from $52.00 to $61.00 and gave the company a "hold" rating in a research note on Thursday, July 17th. Morgan Stanley lowered their target price on Doximity from $71.00 to $60.00 and set an "equal weight" rating on the stock in a research note on Thursday, April 24th. BTIG Research upgraded Doximity from a "neutral" rating to a "buy" rating and set a $80.00 target price on the stock in a research note on Monday, June 2nd. Wells Fargo & Company boosted their target price on Doximity from $55.00 to $62.00 and gave the company an "equal weight" rating in a research note on Monday, August 4th. Finally, Canaccord Genuity Group boosted their target price on Doximity from $50.00 to $59.00 and gave the company a "hold" rating in a research note on Friday, August 8th. Two analysts have rated the stock with a Strong Buy rating, ten have given a Buy rating and ten have issued a Hold rating to the company's stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $66.21.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.